Clinical trials
Arthritis trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 5 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Withdrawn | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Northern Orthopaedic Division, Denmark | 3 |
| Pfizer | 3 |
| University of Aarhus | 3 |
| Bispebjerg Hospital | 2 |
| Eli Lilly and Company | 2 |
| Henning Bliddal | 2 |
| Hvidovre University Hospital | 2 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 2 |
| Zimmer Biomet | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis | 35 |
| Arthritis, Rheumatoid | 9 |
| Osteoarthritis | 8 |
| Arthritis, Juvenile | 5 |
| Joint Diseases | 5 |
| Arthritis, Psoriatic | 4 |
| Musculoskeletal Diseases | 4 |
| Pain | 3 |
| Rheumatic Diseases | 3 |
| Spondylarthritis | 3 |
Trials
Showing 76 to 35 of 35. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.